Westpac Banking Corp’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,796
| Closed | -$1.44M | – | 519 |
|
|
2023
Q2 | $1.44M | Sell |
3,796
-4,459
| -54% | -$1.69M | 0.1% | 225 |
|
|
2023
Q1 | $3.95M | Sell |
8,255
-4,300
| -34% | -$2.06M | 0.05% | 385 |
|
|
2022
Q4 | $5.28M | Buy |
12,555
+750
| +6% | +$315K | 0.08% | 315 |
|
|
2022
Q3 | $4.92M | Hold |
11,805
| – | – | 0.08% | 336 |
|
|
2022
Q2 | $5.84M | Sell |
11,805
-278
| -2% | -$138K | 0.08% | 332 |
|
|
2022
Q1 | $6.81M | Buy |
12,083
+682
| +6% | +$384K | 0.08% | 324 |
|
|
2021
Q4 | $8.61M | Sell |
11,401
-829
| -7% | -$626K | 0.09% | 286 |
|
|
2021
Q3 | $9.12M | Sell |
12,230
-1,100
| -8% | -$821K | 0.1% | 278 |
|
|
2021
Q2 | $8.59M | Buy |
13,330
+400
| +3% | +$258K | 0.09% | 302 |
|
|
2021
Q1 | $7.39M | Sell |
12,930
-1,300
| -9% | -$743K | 0.08% | 312 |
|
|
2020
Q4 | $8.3M | Sell |
14,230
-714
| -5% | -$416K | 0.09% | 285 |
|
|
2020
Q3 | $7.7M | Buy |
14,944
+100
| +0.7% | +$51.5K | 0.1% | 259 |
|
|
2020
Q2 | $6.7M | Buy |
14,844
+13,030
| +718% | +$5.88M | 0.1% | 269 |
|
|
2020
Q1 | $636K | Hold |
1,814
| – | – | 0.01% | 686 |
|
|
2019
Q4 | $671K | Buy |
+1,814
| New | +$671K | 0.01% | 763 |
|
|
2014
Q3 | – | Sell |
-2,391
| Closed | -$286K | – | 933 |
|
|
2014
Q2 | $286K | Buy |
2,391
+777
| +48% | +$93K | ﹤0.01% | 841 |
|
|
2014
Q1 | $207K | Buy |
+1,614
| New | +$207K | ﹤0.01% | 827 |
|